PubRank

Masafumi Takiguchi

Author PubWeight™ 75.83‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009 4.24
2 Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection. J Virol 2004 2.12
3 Three memory subsets of human CD8+ T cells differently expressing three cytolytic effector molecules. J Immunol 2006 1.80
4 Cutting edge: Phenotypic characterization and differentiation of human CD8+ T cells producing IL-17. J Immunol 2009 1.73
5 Amino acid mutation N348I in the connection subdomain of human immunodeficiency virus type 1 reverse transcriptase confers multiclass resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors. J Virol 2008 1.70
6 Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype. J Immunol 2002 1.52
7 Phenotypic classification of human CD8+ T cells reflecting their function: inverse correlation between quantitative expression of CD27 and cytotoxic effector function. Eur J Immunol 2004 1.48
8 A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells. Immunity 2013 1.41
9 Escape from highly effective public CD8+ T-cell clonotypes by HIV. Blood 2011 1.39
10 Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques. J Virol 2006 1.33
11 Different effects of Nef-mediated HLA class I down-regulation on human immunodeficiency virus type 1-specific CD8(+) T-cell cytolytic activity and cytokine production. J Virol 2002 1.31
12 The role of hepatitis B virus-specific memory CD8 T cells in the control of viral replication. J Hepatol 2002 1.30
13 Cutting Edge: Epitope-dependent effect of Nef-mediated HLA class I down-regulation on ability of HIV-1-specific CTLs to suppress HIV-1 replication. J Immunol 2005 1.22
14 Phenotypic classification of human CD4+ T cell subsets and their differentiation. Int Immunol 2008 1.18
15 Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma. Hepatology 2006 1.16
16 CTL-mediated selective pressure influences dynamic evolution and pathogenic functions of HIV-1 Nef. J Immunol 2008 1.13
17 Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naïve patients. Antiviral Res 2009 1.13
18 HIV-1-specific CTLs effectively suppress replication of HIV-1 in HIV-1-infected macrophages. Blood 2007 1.11
19 Small molecule inhibition of HIV-1-induced MHC-I down-regulation identifies a temporally regulated switch in Nef action. Mol Biol Cell 2010 1.10
20 Functional expression of the chemokine receptor CCR5 on virus epitope-specific memory and effector CD8+ T cells. J Immunol 2002 1.09
21 Functionally impaired HIV-specific CD8 T cells show high affinity TCR-ligand interactions. J Immunol 2004 1.08
22 FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia. Int J Cancer 2009 1.05
23 Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4+ T cells and macrophages. J Virol 2009 1.05
24 Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis. Hum Mol Genet 2005 1.01
25 Increased level and longevity of protective immune responses induced by DNA vaccine expressing the HIV-1 Env glycoprotein when combined with IL-21 and IL-15 gene delivery. J Immunol 2006 1.00
26 Multilayered defense in HLA-B51-associated HIV viral control. J Immunol 2011 0.99
27 Effects of naturally-arising HIV Nef mutations on cytotoxic T lymphocyte recognition and Nef's functionality in primary macrophages. Retrovirology 2011 0.99
28 Long-term control of HIV-1 in hemophiliacs carrying slow-progressing allele HLA-B*5101. J Virol 2010 0.99
29 Impact of intrinsic cooperative thermodynamics of peptide-MHC complexes on antiviral activity of HIV-specific CTL. J Immunol 2009 0.99
30 Altering effects of antigenic variations in HIV-1 on antiviral effectiveness of HIV-specific CTLs. J Immunol 2007 0.96
31 Different abilities of escape mutant-specific cytotoxic T cells to suppress replication of escape mutant and wild-type human immunodeficiency virus type 1 in new hosts. J Virol 2007 0.95
32 Early antigen presentation of protective HIV-1 KF11Gag and KK10Gag epitopes from incoming viral particles facilitates rapid recognition of infected cells by specific CD8+ T cells. J Virol 2012 0.93
33 Cutting edge: expression of chemokine receptor CXCR1 on human effector CD8+ T cells. J Immunol 2004 0.93
34 Down-regulation of CXCR4 expression on human CD8+ T cells during peripheral differentiation. Eur J Immunol 2004 0.93
35 Human memory CCR4+CD8+ T cell subset has the ability to produce multiple cytokines. Int Immunol 2009 0.93
36 Selection of escape mutant by HLA-C-restricted HIV-1 Pol-specific cytotoxic T lymphocytes carrying strong ability to suppress HIV-1 replication. Eur J Immunol 2010 0.90
37 HLA class I-mediated control of HIV-1 in the Japanese population, in which the protective HLA-B*57 and HLA-B*27 alleles are absent. J Virol 2012 0.90
38 Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules. J Immunol 2002 0.90
39 Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope. J Virol 2012 0.89
40 Cytotoxic T-cell recognition of HIV-1 cross-clade and clade-specific epitopes in HIV-1-infected Thai and Japanese patients. AIDS 2002 0.89
41 Novel HIV-1 clade B candidate vaccines designed for HLA-B*5101(+) patients protected mice against chimaeric ecotropic HIV-1 challenge. Eur J Immunol 2009 0.88
42 Host-specific adaptation of HIV-1 subtype B in the Japanese population. J Virol 2014 0.88
43 Functional and phenotypic analysis of human memory CD8+ T cells expressing CXCR3. J Leukoc Biol 2006 0.88
44 Functional expression of chemokine receptor CCR6 on human effector memory CD8+ T cells. Eur J Immunol 2007 0.87
45 Impact of vaccination on cytotoxic T lymphocyte immunodominance and cooperation against simian immunodeficiency virus replication in rhesus macaques. J Virol 2011 0.86
46 Unbiased analysis of TCRα/β chains at the single-cell level in human CD8+ T-cell subsets. PLoS One 2012 0.86
47 Determination of a major histocompatibility complex class I restricting simian immunodeficiency virus Gag241-249 epitope. AIDS 2008 0.86
48 Distinct HIV-1 escape patterns selected by cytotoxic T cells with identical epitope specificity. J Virol 2012 0.84
49 Failure of effector function of human CD8+ T Cells in NOD/SCID/JAK3⁻/⁻ immunodeficient mice transplanted with human CD34+ hematopoietic stem cells. PLoS One 2010 0.84
50 A monoclonal antibody to the alpha2 domain of murine major histocompatibility complex class I that specifically kills activated lymphocytes and blocks liver damage in the concanavalin A hepatitis model. J Exp Med 2003 0.83
51 Reconstitution of anti-HIV effector functions of primary human CD8 T lymphocytes by transfer of HIV-specific alphabeta TCR genes. Eur J Immunol 2004 0.82
52 Effective elicitation of human effector CD8+ T Cells in HLA-B*51:01 transgenic humanized mice after infection with HIV-1. PLoS One 2012 0.82
53 Functional heterogeneity of human effector CD8+ T cells. Blood 2011 0.82
54 Different in vivo effects of HIV-1 immunodominant epitope-specific cytotoxic T lymphocytes on selection of escape mutant viruses. J Virol 2010 0.82
55 Comparison of CD4(+) T-cell subset distribution in chronically infected HIV(+) patients with various CD4 nadir counts. Microbes Infect 2010 0.81
56 HLA class I-restricted recognition of an HIV-derived epitope peptide by a human T cell receptor alpha chain having a Vdelta1 variable segment. Eur J Immunol 2003 0.81
57 Peptides presented by HLA class I molecules in the human thymus. J Proteomics 2013 0.81
58 HIV subtype influences HLA-B*07:02-associated HIV disease outcome. AIDS Res Hum Retroviruses 2013 0.80
59 Molecular basis of a dominant T cell response to an HIV reverse transcriptase 8-mer epitope presented by the protective allele HLA-B*51:01. J Immunol 2014 0.80
60 Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistance. AIDS 2010 0.79
61 A strong association of human leukocyte antigen-associated Pol and Gag mutations with clinical parameters in HIV-1 subtype A/E infection. AIDS 2016 0.79
62 Effective recognition of HIV-1-infected cells by HIV-1 integrase-specific HLA-B∗4002-restricted T cells. Microbes Infect 2010 0.78
63 Naturally selected rilpivirine-resistant HIV-1 variants by host cellular immunity. Clin Infect Dis 2013 0.78
64 Identification and characterization of HIV-1 epitopes presented by HLA-A*2603: comparison between HIV-1 epitopes presented by A*2601 and A*2603. Hum Immunol 2006 0.78
65 Patterns of cytokine production in human immunodeficiency virus type 1 (HIV-1)-specific human CD8+ T cells after stimulation with HIV-1-infected CD4+ T cells. J Virol 2005 0.78
66 Identification of cross-clade CTL epitopes in HIV-1 clade A/E-infected individuals by using the clade B overlapping peptides. Microbes Infect 2013 0.78
67 HLA-A*2402-restricted HIV-1-specific cytotoxic T lymphocytes and escape mutation after ART with structured treatment interruptions. Microbes Infect 2008 0.78
68 Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes. AIDS Res Hum Retroviruses 2003 0.78
69 Escape mutation selected by Gag28-36-specific cytotoxic T cells in HLA-A*2402-positive HIV-1-infected donors. Microbes Infect 2008 0.77
70 Toward an effective AIDS vaccine development. Eur J Immunol 2013 0.77
71 Selection of HLA-B57-associated Gag A146P mutant by HLA-B∗48:01-restricted Gag140-147-specific CTLs in chronically HIV-1-infected Japanese. Microbes Infect 2011 0.76
72 Selection and accumulation of an HIV-1 escape mutant by three types of HIV-1-specific cytotoxic T lymphocytes recognizing wild-type and/or escape mutant epitopes. J Virol 2011 0.76
73 Different immunodominance of HIV-1-specific CTL epitopes among three subtypes of HLA-A*26 associated with slow progression to AIDS. Biochem Biophys Res Commun 2007 0.76
74 [Control of HIV infection and selection/ accumulation of HIV escape mutants by HIV-specific cytotoxic T lymphocytes (CTLs)]. Uirusu 2013 0.75
75 [The role of hepatitis B and C virus-specific CTL in the control of viral replication]. Nihon Rinsho Meneki Gakkai Kaishi 2002 0.75
76 Potential for immune-driven viral polymorphisms to compromise antiretroviral-based pre-exposure prophylaxis for prevention of HIV-1 infection. AIDS 2017 0.75
77 Identification and characterization of 2 HIV-1 Gag immunodominant epitopes restricted by Asian HLA allele HLA-B*4801. Hum Immunol 2009 0.75
78 Structural analysis of chick ephrin-A2 by function-blocking and non-blocking monoclonal antibodies. Biochem Biophys Res Commun 2002 0.75
79 A rapid and efficient strategy to generate allele-specific anti-HLA monoclonal antibodies. J Immunol Methods 2009 0.75
80 Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals. Hum Immunol 2009 0.75
81 Identification and characterization of HIV-1-specific CD8+ T cell epitopes presented by HLA-A*2601. Vaccine 2005 0.75
82 CTL recognition of HIV-1-infected cells via cross-recognition of multiple overlapping peptides from a single 11-mer Pol sequence. Eur J Immunol 2012 0.75